Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Prenatal care could be revolutionised suggests studies from BrightHeart

January 31, 2025 Research and Development AI, BrightHeart, FDA, Obstetrics & Gynaecology, prenatal, studies

Private medical device and artificial intelligence (AI)-led company, BrightHeart, has revealed two studies which show an improvement to pre-natal care …
News

MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients

January 30, 2025 Research and Development MHRA, Oncology, approvals, multiple myeloma, rare diseases

The Medicine and Healthcare products Regulatory Agency (MHRA) has approved quadruplet therapy, SARCLISA (isatuximab) in combination to treat multiple myeloma …
News

Positive topline results announced in phase 2 Alcohol Use Disorder study

January 29, 2025 Research and Development Beckley Psytech Ltd, King's College University, Poisoning and drug dependency, alcohol use disorder, clinical trials, positive results

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has …
News

Research collaboration announced between Oxford University and GSK

January 27, 2025 Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …
News

Combination first-in-line treatment approved for patients with non-small cell lung cancer

January 23, 2025 Research and Development J&J Innovative Medicine, Oncology, approval, non-small cell lung cancer

Johnson & Johnson Innovative Medicine  have announced that the European Commission (EC) has approved a marketing authorisation for the combination …
News

Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project 

January 22, 2025 Research and Development Crohns Disease, Crohsn, Gastrointestinal tract, Takeda, biomarkers, ibd, project

Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset …
News

University of Sheffield trial highlights immunotherapy-related improved survival rates for bladder cancer patients

January 14, 2025 Research and Development Endocrinology, Oncology, Sheffield, astranzeneca, bladder cancer, immunotherapy, patients

The University of Sheffield, UK, have announced study results for its trial into the survival rates of patients with operable …
News

AnaCardio raises $19m in funding round for heart failure candidate

January 10, 2025 Research and Development AnaCardio, Cardiology, cardiology, funding, heart failure

Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for …
News

University of Southern Denmark pairs with Argobio to launch next-generation RNA company Inverna Therapeutics

January 7, 2025 Research and Development Argobio, Huntingdon's Disease, Inverna therapeutics, Neurology, RNA therapeutics, University of Southern Denmark ], gene splicing

The launch of new RNA company Inverna Therapeutics was announced today. Inerva Therapeutics begins with a programme aimed at transforming …
News

NDA in China receives priority review status for lung cancer treatment

January 3, 2025 Research and Development China, China National Medical products Administration, HUTCHMED, NDA, Oncology, epidermal growth factor receptor, non-small cell lung cancer, priority review

HUTCHMED have announced that the China National Medical Products Administration (NMPA) have granted a priority review for a new drug …
News

UCB presents epilepsy research at American Epilepsy Society Annual Meeting

December 9, 2024 Research and Development American Epilepsy Society, Dravet Syndrome, Neurology, UCB, sleep

Belgian-based biopharmaceutical company UCB has announced it will present 32 abstracts at the American Epilepsy Society (AES) Annual Meeting – …
News

Antibacterial peptides instrumental in efficiency against resistant bacteria

November 18, 2024 Research and Development AMR, Chalmers Institute of Technology, Infections and infestations, MRSA, antibacterial peptides

This month, the Chalmers University of Technology in Sweden have published the results of a study demonstrating that resistant bacteria, …
News

Spinal cord stimulator with AI technology receives CE Mark certification

November 13, 2024 Research and Development AI, EU, Nevro, Pain, spinal cord stimulation

The HFC iQ, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages AI technology to manage chronic …
News

J&J seek approval for first drug to treat high-risk smoldering myeloma

November 13, 2024 Research and Development FDA, J&J, Rare Diseases, bone marrow

Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the …
News

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024 Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026